Warberg Asset Management’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Warberg Asset Management’s Portfolio SXTPW Stock Details SXTPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-29,515	Closed	-$1.51K	–	227
2024 Q3	$1.51K	Hold	29,515	–	–	﹤0.01%	195
2024 Q2	$2.36K	Hold	29,515	–	–	﹤0.01%	203
2024 Q1	$2.24K	Hold	29,515	–	–	﹤0.01%	193
2023 Q4	$2.07K	Hold	29,515	–	–	﹤0.01%	202
2023 Q3	$10.3K	Buy	+29,515	New	+$12.7K	﹤0.01%	174

Other funds holding SXTPW

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Torno Capital Cohasset, Massachusetts $3.47B AUM 37.88% 1-Year Est. Return

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Warberg Asset Management's SXTPW Position: Q4 2024 in Review

Warberg Asset Management sold out of 60 Degrees Pharmaceuticals Warrant (SXTPW) in Q4 2024, closing a stake of 29,515 shares — an estimated $1.51K sold.

Warberg Asset Management first reported a position in SXTPW in Q3 2023 and held it in 5 quarters. The position peaked at $10.3K in Q3 2023. 7 funds tracked by Wall St. Rank hold SXTPW as of Q4 2024.

Warberg Asset Management reported no remaining 60 Degrees Pharmaceuticals Warrant position as of Q4 2024 after selling out during the quarter.
Warberg Asset Management sold 29,515 60 Degrees Pharmaceuticals Warrant shares in Q4 2024, an estimated $1.51K.
Warberg Asset Management first reported a position in 60 Degrees Pharmaceuticals Warrant in Q3 2023 and held it in 5 quarters.
Warberg Asset Management's 60 Degrees Pharmaceuticals Warrant position peaked at $10.3K in Q3 2023.
7 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q4 2024.

Based on Warberg Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.